Hibiscus sabdariffa : a potential strategy to decrease aging-induced cardiovascular risk? by Farré Alins, Víctor & Universitat Autònoma de Barcelona. Facultat de Biociències
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hibiscus sabdariffa: a Potential Strategy to Decrease Aging-induced  
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 To evaluate the effect of oxidative stress to the main triggers of CVD in elderly. 
 To analyze the scientific evidences of a non-pharmacological treatment which 
provides antioxidant and cardioprotective properties.    
 Progressive and inevitable deterioration of normal functions, which predisposes 
to diseases 
 Main contributor to cardiovascular health in elderly, it is a risk factor for 
cardiovascular disease (CVD) regardless of other risk factors 
Functional and structural changes in heart and arterial system  
 Endothelial dysfunction is associated with an important cause of mortality and 
morbidity 
 Increased levels of oxidative stress  
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3. Materials  and Methods 
 Search for articles in Pubmed database. Keywords used: “cardiovascular aging”,  
“oxidative stress”, “nitric oxide”, “atherosclerosis”, “Hibiscus sabdariffa AND 
hypertension”, “Hibiscus sabdariffa AND atherosclerosis”. 43 articles collected. 
 Search in PubChem database. 
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ATHEROGENESIS 
ROS ONOO 
Reactive oxygen species (ROS), such as OH-, H2O2 or O2
-,  
play a crucial role in aging process. Under normal 
conditions ROS are maintained at physiological levels by 
many antioxidant systems and regulate cell signalling. In 
contrast, increased levels of oxidative stress induce several 
irreversible changes in macromolecules and alter normal 
cell functioning, which leads to cell dysfunction. ROS 
production is increased during aging process, as a 
consequence, it induces endothelial dysfunction. 
Nitric oxide (NO) is the main contributor to blood vessels vasodilatation. ROS induce NO 
degradation; as a result, NO-dependent vasodilatation is reduced. This process not only triggers 
arterial hypertension, but also induce cellular damage through ONOO-. 
ANTIOXIDANT  
CAPACITY 
 Strong dose-dependent antioxidant effect in in vitro assays 
 Increased ability to scavenge ROS in plasma of HS-treated rats 
 HS induced antioxidant enzymes activity 
 Probably polyphenols are the main generators of the effect 
ENDOTHELIAL NO 
 Induction of  eNOS protein, eNOS mRNA and NO production in HS-
treated endothelial cell cultures 
 Vasorelaxant responses in HS-treated aorta rings of hypertensive 
rats, whereas eNOS and cGMP inhibition decreased relaxations 
 Ethyl-acetate extract (containing anthocyanins) had the strongest 
vasorelaxant effects in isolated aorta of male Wistar rats 
 ROS levels increase in aging and contribute to cardiovascular risk 
 HS increases antioxidant capacity and ROS scavenging 
 HS improves endothelial function by increasing NO production 
and preventing LDL oxidation in vitro 
 HS may has an effect on lipid profile 
 Studies in hypertensive patients have demonstrated HS is an 
hypotensive agent 
 Anthocyanins are probably the main contributors to the observed 
effects 
LDL 
 Prevention of LDL oxidation and lipid accumulation in vitro 
 Hypolipidemic effects in HS-treated animals 
 Decreased atherosclerotic levels and foam cell formation in HS-treated rabbits 
Total cholesterol, LDL and triglycerides have been lowered in the majority of 
animal studies. In contrast, HDL was generally not affected 
HYPOTENSIVE 
Figure 3. Endothelial cells incubated with 40 μg/ml of HS extract increased the production of eNOS 
enzyme (A), eNOS mRNA (B) and NO production (C). L-NAME, an inhibitor of eNOS decreased NO 
production. Indomethacin effects, a cicloxigenase inhibitor, were not significant [3]. 
  HYPOLIPIDEMIC ? 
5 studies analyzed: 
 31 patients with metabolic syndrome  
 65 pre- and mildly hypertensive patients 
 60 mildly hypertensive diabetic patients 
 75 mildly and moderately hypertensive patients 
 193 stage 1-2 hypertensive patients 
 Not concluding results 
 Some studies showed an improvement 
of lipid profile, others demonstrated no 
difference in total cholesterol, LDL and 
triglycerides in HS-treated group 
 To find all the bioactive compounds and the molecular 
pathways of its action 
 To standardize the studies: large-scale studies controlled in 
dose, bioactive compounds, bioavailability and other important 
variables 
 To analyze the influence of HS on lipid profile 
 To analyze pharmacological interactions with drugs and 
adverse effects 
 To find an effective dose 
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BIOACTIVE COMPOUNDS 
Figure 4. Left: Delphinidin 3-sambubioside. Right: Cyanidin 3-sambubioside [4]. 
 Anthocyanins, a group of flavonoids (polyphenols), are considered to be the phytochemicals responsible for the 
beneficial effects of HS 
 Particularly delphinidin 3-sambubioside and cyanidin 3-sambubioside are believed to be the major bioactive compounds 
  Anthocyanin metabolits may also contribute to the effects of HS 
 Some scientific evidences of anthocyanin-rich extracts: prevent loss of NO-mediated relaxation, oxidative stress 
protection in endothelial cells, upregulation of eNOS, increased serum antioxidant capacity 
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Figure 1. Mechanism of action of NO in vascular wall and effect 
of ROS in NO bioavailability. Adapted from Vigorito et al. [1]. 
Figure 2. Oxidative stress activates specific signalling pathways that 
lead to atherosclerosis. VSMC, vascular smooth muscle cells; EC, 
endothelial cells. Adapted from Li et al. [2]. 
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Atherosclerosis is a trigger of several CVD. ROS contribute to 
generation of atheromatous plaques in a number of ways. 
Oxidative stress activates a chronic low degree of inflammatory 
response that leads to atherogenesis. Furthermore, ROS oxidise 
LDL lipoproteins (ox-LDL). In the native state LDLs are not 
atherogenic, whereas modified (ox-LDL) can be internalized by 
macrophages and contribute to plaque formation. 
TOXICITY 
Low degree of acute toxicity 
